Redcliffe Labs and Skyroot are partnering on a space-based diagnostic research initiative that carries Redcliffe Labs’ dry diagnostic reagents to Low Earth Orbit. The companies’ maiden project, DRIFT-1, is onboard Skyroot’s mission and is designed to operate for 90 days in orbit.
The DRIFT-1 study evaluates how the reagents perform under space conditions. According to the report, the experiment includes a direct comparison between samples tested in orbit and an identical ground-control set kept on Earth, allowing researchers to assess differences in performance attributable to the orbital environment.
Both outlets describe the collaboration as a diagnostic-focused research effort rather than an immediate commercial deployment. The coverage centers on the mission’s purpose and the structure of the evaluation, with emphasis on the duration in orbit and the paired ground-control comparison. No other differing claims were provided in the excerpts beyond these shared elements.
